MRNA vs SGMO · rev $145.0M vs rev $57.8M
Moderna Inc (MRNA) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
MRNA currently screens at market cap $24.52B. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the MRNA and SGMO stock pages for the full models.
Not investment advice.